India’s Generic Copies Dent Eli Lilly’s Sales

This is a live story built from multiple sources. It may evolve quickly.

Coverage meter • 1 min window

Back to home Open top source

B bloomberg.com

What’s included

Top recent items from this story.

1 items • 1 unique links

Bloomberg Markets 3 days ago • bloomberg.com

India’s Generic Copies Dent Eli Lilly’s Sales

The flood of cheap copies of Novo Nordisk A/S’ blockbuster drug semaglutide in India is already reshaping the country’s fast-growing obesity market, cutting into Eli Lilly & Co.’s early lead and offering a first real tes…

Open